SeaStar Medical (ICU) Competitors

$4.06

-0.04 (-0.98%)

(As of 11:33 AM ET)

ICU vs. EUCR, COCH, ECOR, ICAD, APYX, LUCD, CODX, SURG, ALUR, and OM

Should you be buying SeaStar Medical stock or one of its competitors? The main competitors of SeaStar Medical include Eucrates Biomedical Acquisition (EUCR), Envoy Medical (COCH), electroCore (ECOR), iCAD (ICAD), Apyx Medical (APYX), Lucid Diagnostics (LUCD), Co-Diagnostics (CODX), SurgePays (SURG), Allurion Technologies (ALUR), and Outset Medical (OM).

SeaStar Medical vs.

SeaStar Medical (NASDAQ:ICU) and Eucrates Biomedical Acquisition (NASDAQ:EUCR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, community ranking, analyst recommendations, earnings and media sentiment.

: In the previous week, SeaStar Medical had 5 more articles in the media than Eucrates Biomedical Acquisition. MarketBeat recorded 5 mentions for SeaStar Medical and 0 mentions for Eucrates Biomedical Acquisition. SeaStar Medical's average media sentiment score of 0.65 beat Eucrates Biomedical Acquisition's score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the media.
Company Overall Sentiment
SeaStar Medical Positive
Eucrates Biomedical Acquisition Neutral
: SeaStar Medical's return on equity of 0.00% beat Eucrates Biomedical Acquisition's return on equity.
Company Net Margins Return on Equity Return on Assets
SeaStar Medical N/A N/A -666.82%
Eucrates Biomedical Acquisition N/A -62.82% 2.95%
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SeaStar Medical N/A N/A -$26.23M -$25.00 -0.16
Eucrates Biomedical Acquisition N/A N/A $2.42M N/A N/A
: SeaStar Medical has a beta of -1.14, meaning that its share price is 214% less volatile than the S&P 500. Comparatively, Eucrates Biomedical Acquisition has a beta of -0.07, meaning that its share price is 107% less volatile than the S&P 500.
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Eucrates Biomedical Acquisition
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: 1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 56.0% of Eucrates Biomedical Acquisition shares are held by institutional investors. 3.0% of SeaStar Medical shares are held by company insiders. Comparatively, 19.5% of Eucrates Biomedical Acquisition shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
: SeaStar Medical received 1 more outperform votes than Eucrates Biomedical Acquisition when rated by MarketBeat users.
Company Underperform Outperform
SeaStar Medical Outperform Votes
1
100.00%
Underperform Votes
No Votes
Eucrates Biomedical Acquisition N/A N/A

Company	Overall Sentiment
SeaStar Medical	Positive
Eucrates Biomedical Acquisition	Neutral

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	N/A	N/A	-666.82%
Eucrates Biomedical Acquisition	N/A	-62.82%	2.95%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	N/A	N/A	-$26.23M	-$25.00	-0.16
Eucrates Biomedical Acquisition	N/A	N/A	$2.42M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Eucrates Biomedical Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Underperform	Outperform
SeaStar Medical	Outperform Votes 1 100.00%	Underperform Votes No Votes
Eucrates Biomedical Acquisition	N/A	N/A

Summary

Eucrates Biomedical Acquisition beats SeaStar Medical on 5 of the 9 factors compared between the two stocks.

Ad TradingTips

7 Cheap and Good Stocks

It's the holy grail of the stock market... Stocks that trade for pennies on the dollar yet have the potential to skyrocket for monster gains. Well, we've uncovered SEVEN such stocks.

Simply follow this link and claim your copy today at no charge whatsoever.

Get SeaStar Medical News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ICU vs. The Competition

Export to Excel

Metric	SeaStar Medical	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$13.08M	$3.99B	$5.47B	$8.49B
Dividend Yield	N/A	28.46%	4.33%	4.14%
P/E Ratio	-0.21	25.51	141.01	19.38
Price / Sales	N/A	66.35	1,190.90	86.28
Price / Cash	N/A	38.12	37.65	33.48
Price / Book	-0.65	3.97	4.66	4.57
Net Income	-$26.23M	$56.63M	$118.89M	$226.60M
7 Day Performance	3.05%	2.89%	2.53%	3.21%
1 Month Performance	-17.06%	17.69%	15.57%	12.47%
1 Year Performance	-68.70%	37.37%	29.56%	25.98%

SeaStar Medical Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ICU SeaStar Medical	0.4985 of 5 stars	$4.06 -1.0%	N/A	-68.4%	$13.08M	N/A	-0.21	2	Short Interest ↑
EUCR Eucrates Biomedical Acquisition	N/A	$10.04 flat	N/A	+0.0%	$42.27M	N/A	0.00	4	High Trading Volume
COCH Envoy Medical	3.0537 of 5 stars	$2.60 +6.6%	$7.92 +204.5%	+2.5%	$50.96M	$302,000.00	0.00	34	Analyst Forecast News Coverage Positive News Gap Down
ECOR electroCore	1.7093 of 5 stars	$7.59 -3.1%	N/A	+44.7%	$45.59M	$21.28M	-3.45	50	Short Interest ↓ News Coverage
ICAD iCAD	0.4771 of 5 stars	$1.60 +4.6%	N/A	-10.5%	$42.46M	$18.80M	-14.55	67	Positive News
APYX Apyx Medical	4.5259 of 5 stars	$1.20 +3.4%	$5.00 +316.7%	-50.7%	$41.57M	$49.03M	-1.46	270	Positive News
LUCD Lucid Diagnostics	2.7426 of 5 stars	$0.77 -1.2%	$3.94 +411.4%	-36.1%	$40.36M	$3.80M	-0.63	70
CODX Co-Diagnostics	3.8922 of 5 stars	$1.29 -2.3%	$1.50 +16.3%	+24.5%	$40.33M	$9.14M	-1.02	100	Short Interest ↓ Positive News
SURG SurgePays	4.0537 of 5 stars	$1.80 -3.2%	$9.00 +400.0%	-60.1%	$35.55M	$137.14M	20.00	22	Positive News
ALUR Allurion Technologies	1.9802 of 5 stars	$0.67 -1.4%	$2.88 +328.0%	-85.6%	$32.21M	$47.59M	-0.76	501	Gap Up
OM Outset Medical	2.7943 of 5 stars	$0.60 -0.4%	$4.70 +689.0%	-82.4%	$30.81M	$116.43M	-0.19	520	Short Interest ↓